You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

homozygous familial hypercholesterolemia

Showing 1 - 25 of 1,545
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Homozygous Familial Hypercholesterolemia Trial in Xi'an (NGGT006)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • NGGT006
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Nov 5, 2023

Homozygous Familial Hypercholesterolemia Trial (SHR-1918)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • (no location specified)
Aug 22, 2023

Homozygous Familial Hypercholesterolemia Trial (Evinacumab)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • (no location specified)
Nov 3, 2022

Homozygous Familial Hypercholesterolemia Trial in Beijing (IBI306)

Active, not recruiting
  • Homozygous Familial Hypercholesterolemia
  • IBI306
  • Beijing, China
    Beijing Anzhen Hospital, Capital Medical University
Sep 12, 2022

Patients With High Cholesterol and Normal Volunteers

Completed
  • Homozygous Familial Hypercholesterolemic
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 12, 2023

    Homozygous Familial Hypercholesterolemia Trial in Worldwide (Evinacumab)

    Active, not recruiting
    • Homozygous Familial Hypercholesterolemia
    • Wilmington, Delaware
    • +10 more
    Jan 30, 2023

    The Rogosin Institute Homozygous Familial Hypercholesterolemia

    Recruiting
    • Homozygous Familial Hypercholesterolemia
      • New York, New York
        The Rogosin Institute, Weill Cornell Medical College
      Feb 28, 2022

      Homozygous Familial Hypercholesterolemia Trial in Australia, Canada, United States (ARO-ANG 3 Injection)

      Recruiting
      • Homozygous Familial Hypercholesterolemia
      • ARO-ANG 3 Injection
      • Mount Sinai, New York
      • +7 more
      Sep 26, 2022

      Heterozygous or Homozygous Familial Hypercholesterolemia Trial (Inclisiran)

      Not yet recruiting
      • Heterozygous or Homozygous Familial Hypercholesterolemia
      • (no location specified)
      Dec 27, 2022

      Homozygous Familial Hypercholesterolemia Trial in Netherlands, South Africa, United States (Demographics, diagnosis type,

      Recruiting
      • Homozygous Familial Hypercholesterolemia
      • Demographics, diagnosis type, genotype, lipid profile, treatment allocation, country of residence.
      • Philadelphia, Pennsylvania
      • +3 more
      Sep 28, 2022

      Ezetimibe onSelect Population of Filipinos With

      Completed
      Has Results
      • Primary Hypercholesterolemia
      • Homozygous Familial Hypercholesterolemia
      • (no location specified)
      Feb 7, 2022

      Vytorin Reexamination Study (0653A-174)

      Completed
      Has Results
      • Primary Hypercholesterolemia and Homozygous Familial Hypercholesterolemia (HoFH)
        • (no location specified)
        Feb 7, 2022

        Hyperlipemia Trial in Beijing (JS002)

        Active, not recruiting
        • Hyperlipemia
        • Beijing, Beijing, China
          Beijing Anzhen Hospital Capital Medical University
        Jan 24, 2022

        Familial Hypercholesterolemia - Homozygous, Lipid Metabolism Disorders, Proprotein Convertase Subtilisin/Kexin 9 Trial in

        Recruiting
        • Familial Hypercholesterolemia - Homozygous
        • +2 more
        • IBI306
        • Shenzhen, Guangdong, China
          xili People's Hospital
        Jun 29, 2021

        Homozygous Familial Hypercholesterolemia Trial in Worldwide (lerodalcibep, evolocumab)

        Active, not recruiting
        • Homozygous Familial Hypercholesterolemia
        • Evanston, Illinois
        • +11 more
        Jul 13, 2022

        Identifying and Genotyping Homozygous Familial

        Completed
        • Homozygous Familial Hypercholesterolemia (HoFH)
          • Boca Raton, Florida
            Excel Medical Clinical Trials, LLC
          Jan 28, 2021

          Homozygous Familial Hypercholesterolemia Trial in Worldwide (evinacumab)

          Active, not recruiting
          • Homozygous Familial Hypercholesterolemia
          • Los Angeles, California
          • +37 more
          Feb 17, 2022

          Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH)

          Active, not recruiting
          • Lipoprotein Lipase Deficiency
          • +2 more
            • Rostock, Germany
            • +3 more
            May 12, 2021

            Homozygous Familial Hypercholesterolemia Trial in Worldwide (Alirocumab, Placebo)

            Completed
            Has Results
            • Homozygous Familial Hypercholesterolemia
            • Boca Raton, Florida
            • +27 more
            Jun 7, 2021

            Homozygous Familial Hypercholesterolemia Trial in France (Whole Genome Sequencing)

            Completed
            • Homozygous Familial Hypercholesterolemia
            • Whole Genome Sequencing
            • Dijon, France
            • +8 more
            May 21, 2021

            Homozygous Familial Hypercholesterolemia HoFH Trial in India (evolocumab)

            Completed
            Has Results
            • Homozygous Familial Hypercholesterolemia HoFH
            • New Delhi, Delhi, India
            • +11 more
            Nov 13, 2020

            Homozygous Familial Hypercholesterolemia Trial in Worldwide (evinacumab, Placebo)

            Completed
            Has Results
            • Homozygous Familial Hypercholesterolemia
            • Boca Raton, Florida
            • +29 more
            Apr 26, 2021

            Hypercholesterolemia, Familial Trial in Philadelphia, Amsterdam (Kinetics test)

            Completed
            • Hypercholesterolemia, Familial
            • Kinetics test
            • Philadelphia, Pennsylvania
            • +1 more
            May 14, 2021

            Study to Evaluate the Safety and Efficacy of RGX-501

            Active, not recruiting
            • Homozygous Familial Hypercholesterolemia (HoFH)
            • Single intravenous (IV) dose of human Low Density Lipoprotein Receptor (LDLR) Gene Therapy
            • Columbus, Ohio
            • +5 more
            Jun 7, 2021

            Homozygous Familial Hypercholesterolaemia (HoFH) Trial in Worldwide (Lomitapide)

            Recruiting
            • Homozygous Familial Hypercholesterolaemia (HoFH)
            • Heidelberg, Baden-Wurttemberg, Germany
            • +13 more
            Apr 4, 2022